Peter Greenleaf

Affiliations

  • Chief Executive Officer at Aurinia Pharmaceuticals Inc. (AUPH), 2024-03-07
  • Director at Antares Pharma Inc. (ATRS), 2022-05-26
  • Director at Biodelivery Sciences International Inc (BDSI), 2022-03-22
  • Director at Cerecor Inc. (CERC), 2019-10-03
  • Director at Eyegate Pharmaceuticals Inc (EYEG), 2019-02-05
  • Chief Executive Officer at Sucampo Pharmaceuticals Inc. (SCMP), 2018-02-13
  • Director at Mast Therapeutics Inc. (MSTX), 2017-01-23
  • Director at Mirna Therapeutics Inc. (MIRN), 2016-09-06
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AUPH $11.11 2,992 Officer, Director 13,453 2021-05-11 Filing
AUPH $10.15 2,133 Officer, Director 10,461 2021-05-11 Filing
CERC $3.98 12,500 Officer, Director 412,500 2018-05-18 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AUPH $5.60 126,981 Officer, Director 1,522,114 2024-03-06 Filing
AUPH $8.78 33,047 Officer, Director 982,671 2023-03-02 Filing
AUPH $8.94 32,750 Officer, Director 982,968 2023-03-02 Filing
AUPH $12.01 9,068 Officer, Director 32,967 2022-03-02 Filing
SCMP $16.75 82,459 Officer 2,513 2016-11-29 Filing